Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study - Wikidata - wikimedia - TriplyDB

Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study

Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study

http://www.wikidata.org/entity/Q35872344

about

Statin treatment in multiple sclerosis: a systematic review and meta-analysis.A randomized controlled phase II trial of riluzole in early multiple sclerosis.Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.Association of multiple sclerosis susceptibility variants and early attack location in the CNS Placebo-controlled study in neuromyelitis optica-Ethical and design considerations A Journey in Science: The Privilege of Exploring the Brain and the Immune System.Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis.Neuroprotection in multiple sclerosis: a therapeutic approach.Disease modification in multiple sclerosis: an update.Development of therapies for autoimmune disease at Stanford: a tale of multiple shots and one goal.Immunometabolism and autoimmunity.Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection.Piet Mondrian's trees and the evolution in understanding multiple sclerosis, Charcot Prize Lecture 2011.

P2860

Q30913423-C8FAF487-AA8E-4DFC-A3BD-013226DC0FC7 Q34286809-F10BB9DD-CCD3-4D99-88FA-45CFBCD49E62 Q35018274-6CA466AE-FE07-4463-BC6C-C1E9E020BA80 Q35018315-E5707E8B-D5DF-4352-ADD0-E899D813BBB4 Q36996492-CCCE4EDB-F6C2-4EE6-A99C-1953FAA5F97C Q37217037-9FE3C841-BF67-4C9F-AD29-C89FB3199606 Q37580266-A4B1C0F0-0545-40DE-8980-73D084D066E7 Q37676004-C96B664D-A967-41ED-A073-E769C1B3E78F Q38129748-BBC4B212-73A3-4FC8-A15F-A0B5191D9506 Q38150823-4DFCDC97-24F6-46C7-8EEB-154E9BB4842F Q38207555-6F63168B-B001-43FA-A7D9-F334543E0B87 Q38937346-CA2AE295-32B2-4BCD-BF62-8331024680D8 Q41167369-349B6E20-7681-4658-9A41-4E881B09E10C Q48285545-5D8181DC-0226-433C-BE37-76D7BE0EC663

P2860

Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study

http://www.wikidata.org/entity/Q35872344

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Randomized controlled trial of ...... ed syndrome: the STAyCIS study

@ast

Randomized controlled trial of ...... ed syndrome: the STAyCIS study

@en

type

label

Randomized controlled trial of ...... ed syndrome: the STAyCIS study

@ast

Randomized controlled trial of ...... ed syndrome: the STAyCIS study

@en

prefLabel

Randomized controlled trial of ...... ed syndrome: the STAyCIS study

@ast

Randomized controlled trial of ...... ed syndrome: the STAyCIS study

@en

P1433

Q35872344-4EAF5FD3-0E7D-4BE2-9F82-7E67A70DC9CE

P1476

Q35872344-4AB3F224-6C78-4CA4-A9B2-D55FD725C164

P2093

Q35872344-0416CFBA-BBDF-47AB-AED4-21B23444A424

Q35872344-0B1D8EC1-26F4-4906-BD12-CB17F8EB0549

Q35872344-0B7240D4-F815-465D-9685-95B648E04895

Q35872344-1D3B4A18-CD1B-46A3-A0A5-BB754E12E3DA

Q35872344-24167923-6156-4775-9149-019D64D037EC

Q35872344-2DFC4DC7-01CA-40E4-827D-5EDEF0F9E202

Q35872344-2E23D8DE-7BFA-481D-81E6-848BD2BA5106

Q35872344-50E7F6DE-D546-4331-929C-3AA81D804155

Q35872344-56BD0B99-8AA1-47ED-AE3F-727C0788EBE4

Q35872344-59C95158-71E2-46B5-9C4D-3394D7B9513E

P2860

Q35872344-0A8F1EE2-E101-4DD0-AE20-428FB363A34A

Q35872344-118653BC-923F-4A16-A388-F3FC27AF482D

Q35872344-2FBD9BB0-5469-49E8-979B-3C112BC49C13

Q35872344-37DEC551-08EA-4251-B1A3-78FBB1D15B3A

Q35872344-407E94B1-0D39-4A96-9340-CF9D466C2804

Q35872344-56227880-4893-4956-9F2C-63752F195911

Q35872344-5B86AB69-37A2-41CA-B9DB-92BA996E95AB

Q35872344-7F4C9861-B259-4F29-8825-06BC4D64774B

Q35872344-8F6E1B1D-202A-4410-B158-96EA37F5179E

Q35872344-A2999B1C-B476-4CD5-9CD7-2DBF9F1D95DE

P304

Q35872344-EEBF972F-2156-4497-ABA7-3A4C10AEA71A

P31

Q35872344-BEB28DF0-53F4-45D3-AF6A-DD12CD3FE7E7

P356

Q35872344-208CEA9A-04D6-44CC-BB49-8D8F782374C3

P407

Q35872344-7C3EB8A7-0935-4580-9C93-6FD2AAE8E442

P433

Q35872344-CEBFEA01-C026-4CE9-BC50-90119B23F914

P478

Q35872344-674DB508-2D91-4428-94C5-D30CDF848504

P50

Q35872344-CAC924B2-A9C1-4530-B61B-4EAFAC20D15F

Q35872344-FDD571B1-D735-449C-B8BC-B69E270ADCB2

P577

Q35872344-F1ADB47A-FEB2-4D5A-8667-B5F0781B2091

P698

Q35872344-9F55BA7F-AF18-4F83-A846-DC3E8F209AF6

P932

Q35872344-ACD913A3-05B2-48AB-A0AF-E42991566AA3

P356

WNL.0B013E31824F7FDD

P1433

P1476

Randomized controlled trial of ...... ed syndrome: the STAyCIS study

@en

P2093

A Bar-Or

http://www.w3.org/2001/XMLSchema#string

A Cross

http://www.w3.org/2001/XMLSchema#string

A Goodman

http://www.w3.org/2001/XMLSchema#string

A Miller

http://www.w3.org/2001/XMLSchema#string

B Weinstock-Guttman

http://www.w3.org/2001/XMLSchema#string

C Spencer

http://www.w3.org/2001/XMLSchema#string

D Iklé

http://www.w3.org/2001/XMLSchema#string

D Pelletier

http://www.w3.org/2001/XMLSchema#string

E Rosenberg

http://www.w3.org/2001/XMLSchema#string

H Kopetskie

http://www.w3.org/2001/XMLSchema#string

P2860

Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a.

Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity.

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.

Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin.

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin

Simvastatin inhibits IFN-gamma-induced CD40 gene expression by suppressing STAT-1alpha.

P304

1171-1178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E31824F7FDD

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

Emmanuelle Waubant

Peter A Calabresi

P577

2012-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22459680

http://www.w3.org/2001/XMLSchema#string

P932

3320055

http://www.w3.org/2001/XMLSchema#string